Unmasking the tumourigenic role of SIN1/MAPKAP1 in the mTOR complex 2
Abstract Background Although the PI3K/AKT/mTOR pathway is one of the most altered pathways in human tumours, therapies targeting this pathway have shown numerous adverse effects due to positive feedback paradoxically activating upstream signaling nodes. The somewhat limited clinical efficacy of thes...
Main Authors: | Emilien Ezine, Céleste Lebbe, Nicolas Dumaz |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-10-01
|
Series: | Clinical and Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/ctm2.1464 |
Similar Items
-
Recent advances and limitations of mTOR inhibitors in the treatment of cancer
by: Eunus S. Ali, et al.
Published: (2022-09-01) -
The Bumpy Road towards mTOR Inhibition in Glioblastoma: Quo Vadis?
by: Kostas A. Papavassiliou, et al.
Published: (2021-12-01) -
Dysregulation of mTOR Signaling after Brain Ischemia
by: Mario Villa-González, et al.
Published: (2022-03-01) -
RICTOR Affects Melanoma Tumorigenesis and Its Resistance to Targeted Therapy
by: Ahlem Jebali, et al.
Published: (2021-10-01) -
Not only a therapeutic target; mTOR in Hodgkin lymphoma and acute lymphoblastic leukemia
by: Miguel Enrique Cuéllar Mendoza, et al.
Published: (2024-02-01)